Glen Waverly, Australia

Chrishan S Samuel


 

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2010-2017

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Chrishan S Samuel

Introduction

Chrishan S Samuel is an accomplished inventor based in Glen Waverly, Australia. He has made significant contributions to the field of molecular medicine, particularly in the area of apoptosis modulation. With a total of 2 patents to his name, Samuel's work has the potential to impact various medical applications.

Latest Patents

Samuel's latest patents focus on the methods of modulating apoptosis through the administration of relaxin agonists or antagonists. The inventions highlight the discovery that relaxin plays a crucial role in the development and maturation of body tissues. Notably, knockouts of the gene encoding relaxin lead to various abnormalities in tissue development. His patents provide innovative methods for modulating apoptosis by administering relaxin agonists or antagonists to subjects, showcasing his commitment to advancing medical science.

Career Highlights

Samuel is affiliated with the Molecular Medicine Research Institute, where he conducts his research and development. His work at the institute emphasizes the importance of understanding the biological mechanisms behind tissue development and apoptosis. Samuel's dedication to his field is evident in his innovative approaches and research findings.

Collaborations

Samuel collaborates with various professionals in his field, including his coworker Edward P Amento. These collaborations enhance the research environment and foster the exchange of ideas, contributing to the advancement of their shared goals in molecular medicine.

Conclusion

Chrishan S Samuel is a notable inventor whose work in apoptosis modulation has the potential to transform medical practices. His patents and research at the Molecular Medicine Research Institute reflect his commitment to innovation and scientific advancement.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…